BVMF/B1MR34 (BVMF/B1MR34)

Brazil Stock Exchange: BVMF/B1MR34 · BRL

R$144

+0.00 (0.0%)· Recorded snapshot

Market cap	58.2B
Revenue (ttm)	17.6B
Net income (ttm)	378.1M
EPS (ttm)	R$1.01
P/E (trailing)	142.2x
P/E (forward)	11.5x
Volume	0
Beta	0.21

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 17.6B
Net income (ttm): 378.1M
EPS (ttm): R$1.01
P/E (trailing): 142.2x
P/E (forward): 11.5x
Market cap: 58.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E11.5

P25 n/aP50 n/aP75 n/a

Trailing P/E142.2

P25 n/aP50 n/aP75 n/a

ROE1.2

P25 n/aP50 n/aP75 n/a

ROIC3.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/B1MR34 indicators

Market & fundamental data

Available fields

229

Groups with data

Currency

USD

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-02
Employees	3,221
Employees change	181
Employees growth	5.95%
Enterprise value	BRL 76.1B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1996
Industry	Biotechnology
Is primary listing	No
ISIN number	BRB1MRBDR001
Last earnings date	2026-08-06
Last refreshed	2026-10-29
Market cap	BRL 58.2B
Next earnings date	2026-11-02
Price	BRL 144.05
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-15
Symbol	bvmf/B1MR34
Website	https://www.biomarin.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	135.19x
Average P/E ratio (3Y)	60.01x
Average P/E ratio (5Y)	157.57x
Earnings yield	0.7%
EV/Earnings	201.36x
EV/EBIT	28.35x
EV/EBITDA	21.62x
EV/FCF	19.91x
EV/Sales	4.16x
FCF / EV yield	5.02%
FCF yield	6.57%
Forward P/E	11.46x
Graham number	41.28048
Graham upside	-71.34%
Lynch fair value	BRL 4.68
Lynch upside	-96.75%
P/(FCF - SBC) ratio	21.5x
P/(OCF - SBC) ratio	17.52x
P/B ratio	1.78x
P/E ratio	142.19x
P/FCF ratio	15.23x
P/OCF ratio	13.12x
P/S ratio	3.3x
Price / tangible book value	14.29x
Price/EBITDA ratio	17.42x
Sector forward P/E	11.07x
Sector P/E	40.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	14.67%
EBITDA margin	18.94%
Effective tax rate	51.06%
FCF margin	21%
Gross margin	50.97%
Operating margin	14.67%
Pretax margin	4.38%
Profit margin	2.14%
Profit per employee	BRL 117,371
Profitable quarters	2
Profitable years	4
Revenue per employee	BRL 5.5M
ROA	3.26%
ROA (5Y)	2.28%
ROCE	4.97%
ROE	1.18%
ROE (5Y)	3.83%
ROIC	3.24%
ROIC (5Y)	3.88%
SBC / revenue	6.32%
Tax / revenue	2.24%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-88.85%
EPS growth (Q)	-81.3%
EPS growth (QoQ)	-57.65%
EPS growth 3Y	-10.29%
EPS growth 5Y	-38.77%
EPS growth years	0
FCF growth	6.23%
FCF growth (Q)	-17.17%
FCF growth (QoQ)	-30.26%
FCF growth 3Y	144.98%
FCF growth 5Y	33.6%
Gross profit growth	-1.29%
Gross profit growth (Q)	15.11%
Gross profit growth 3Y	18.44%
Gross profit growth 5Y	18.57%
Net income growth	-88.9%
Net income growth (Q)	-81.39%
Net income growth (QoQ)	-57.58%
Net income growth 3Y	-9.97%
Net income growth 5Y	-38.61%
Net income growth years	0
OCF growth	11.78%
OCF growth (Q)	-9.26%
OCF growth (QoQ)	-23.81%
OCF growth 3Y	74.52%
OCF growth 5Y	26.07%
Operating income growth	-35.61%
Operating income growth (Q)	-24.36%
Operating income growth 3Y	58.48%
Revenue growth	11.2%
Revenue growth (Q)	19.91%
Revenue growth (QoQ)	29.17%
Revenue growth 10Y	13.34%
Revenue growth 3Y	15.09%
Revenue growth 5Y	12.19%
Revenue growth quarters	18
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -616M
Depreciation and amortization	BRL 778.3M
EBIT	BRL 2.6B
EBITDA	BRL 3.3B
EPS	BRL 1.01
Financing cash flow	BRL 18.4B
Free cash flow	BRL 3.8B
Free cash flow minus SBC	BRL 2.7B
Gross profit	BRL 9B
Income taxes	BRL 394.5M
Investing cash flow	BRL -24.6B
Net borrowing	BRL 19.5B
Net cash flow	BRL -1.8B
Net income	BRL 378.1M
Operating cash flow minus SBC	BRL 3.3B
Operating income	BRL 2.6B
Revenue	BRL 17.6B
Stock-based compensation	BRL 1.1B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.9
Book value per share	BRL 169.23
Debt / EBITDA	6.41
Debt / equity	0.66
Debt / FCF	5.69
Goodwill	BRL 3.5B
Interest coverage	5.98
Long-term assets	BRL 39.5B
Long-term liabilities	BRL 19.1B
Net cash (debt)	BRL -17.2B
Net cash / market cap	-29.6%
Net debt / EBITDA	5.16
Net debt / equity	0.53
Net debt / FCF	4.51
Piotroski F-Score	4
Property, plant and equipment	BRL 5.3B
Shareholders' equity	BRL 32.8B
Tangible book value	BRL 4.1B
Tangible book value per share	BRL 21.06
Total assets	BRL 60.7B
Total cash	BRL 4.5B
Total debt	BRL 21.8B
Total liabilities	BRL 28B
WACC	4.22%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.36
Current assets	BRL 21.2B
Current liabilities	BRL 8.9B
Current ratio	2.39
Inventory turnover	1.07
Net working capital	BRL 10.9B
Quick ratio	1.16
Working capital	BRL 12B
Working capital turnover	6.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.61%
Shareholder yield	-0.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 161.97
1D price change	0%
1M price change	-13.24%
1M total return	-13.24%
1W price change	1.42%
1W total return	1.42%
1Y price change	0.19%
1Y return CAGR	0.19%
1Y total return	0.19%
20-day SMA	BRL 160.12
200-day SMA	BRL 177.52
3M price change	-3.61%
3M total return	-3.61%
3Y price change	-35.21%
3Y return CAGR	-13.47%
3Y total return	-35.21%
50-day SMA	BRL 152.19
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 174.41
52-week high date	2026-08-21
52-week low	BRL 123.51
52-week low date	2026-05-18
5Y price change	-32.71%
5Y return CAGR	-7.62%
5Y total return	-32.71%
6M price change	3.28%
6M total return	3.28%
All-time high	BRL 348.85
All-time high date	2020-07-20
All-time low	BRL 123.51
All-time low date	2026-05-18
Average true range (ATR)	BRL 4.04
Average volume	165.3
Beta (5Y)	0.22
Change from 52-week high	-17.41%
Change from 52-week low	16.63%
Change from all-time high	-58.71%
Change from all-time low	16.63%
Change from open	0%
Day's gap	0%
High price	BRL 144.05
Low price	BRL 144.05
Monthly RSI	43.38
Open price	BRL 144.05
Previous close	BRL 144.05
Price vs 150-day SMA	-11.06%
Price vs 20-day SMA	-10.03%
Price vs 200-day SMA	-18.86%
Price vs 50-day SMA	-5.35%
Relative volume	0.3
RSI	40.22
Sharpe ratio	-0.93
Sortino ratio	-1.18
Volume	0
Weekly RSI	42.41
YTD price change	-13.75%
YTD total return	-13.75%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	192.6M
Shares change (QoQ)	-1.62%
Shares change (YoY)	0.61%
Shares held by insiders	0.4%
Shares held by institutions	102.68%
Short ratio	5.4 days

Deeper analysis on BVMF/B1MR34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/B1MR34 report

Is a complete BVMF/B1MR34 research report available?

No complete published report is available for bvmf/B1MR34 (BVMF/B1MR34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/B1MR34 (BVMF/B1MR34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/B1MR34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/B1MR34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/B1MR34

Frequently asked questions